Skip to content

Study · Not a test of the peptide alone · 2015

1 result

RF9 Acts as a KISS1R Agonist In Vivo and In Vitro.

Min L, Leon S, Li H, Pinilla L, Carroll RS, Tena-Sempere M, Kaiser UB

Endocrinology29 Sept 2015Cited by 29 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Kisspeptin-10 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Kisspeptin-10.

  1. 01LabNot a test of Kisspeptin-10 aloneIn vitro (cells)Activity measurement

    In KISS1R-transfected CHO cells, RFRP-3 did not alter the responses to kisspeptin‑10 or RF9; kisspeptin‑10 served as a reference agonist for testing RF9.

    In plain wordsIn cells, RFRP-3 did not change how the cells responded to kisspeptin‑10.

    Outcome
    No significant changeKisspeptin-10 responses with RFRP-3 (inositol phosphate, pERK)
    Study

    Chinese hamstern: not reported in source

    CHO cells stably transfected with KISS1R
    Outcome group
    Receptor activity and mechanism · Reproductive and sexual health

    Source sentences

    Summary
    RFRP-3, the putative endogenous ligand for NPFFR1, did not stimulate inositol phosphate accumulation or pERK, nor did it alter responses to of kisspeptin-10 or RF9.
    1 context sentence
    Summary · context
    Using Chinese Hamster Ovary cells stably transfected with KISS1R, we show that RF9 binds specifically to KISS1R, with a Kd of 1.6 × 10(-5)M, and stimulates an increase in intracellular calcium and inositol phosphate accumulation in a KISS1R-dependent manner, with EC50 values of 3.0 × 10(-6)M and 1.6…

    In this study, Kisspeptin-10 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Kisspeptin-10.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.